Edition:
United Kingdom

Ardelyx Inc (ARDX.OQ)

ARDX.OQ on NASDAQ Stock Exchange Global Market

2.99USD
16 Nov 2018
Change (% chg)

$0.06 (+2.05%)
Prev Close
$2.93
Open
$2.88
Day's High
$3.09
Day's Low
$2.80
Volume
68,005
Avg. Vol
63,787
52-wk High
$8.07
52-wk Low
$2.54

Chart for

About

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical products segment. The Company's products line includes cardiorenal portfolio and... (more)

Overall

Beta: 0.24
Market Cap(Mil.): $268.07
Shares Outstanding(Mil.): 47.45
Dividend: --
Yield (%): --

Financials

  ARDX.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -2.44 -- --
ROI: -79.45 -0.64 15.05
ROE: -79.86 0.08 16.62

BRIEF-Ardelyx Announces Pricing Of Public Offering Of Common Stock

* ARDELYX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

22 May 2018

BRIEF-Ardelyx Announces Proposed Public Offering Of Common Stock

* ARDELYX INC - STARTED UNDERWRITTEN PUBLIC OFFERING OF UP TO $50 MLN OF SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage:

21 May 2018

Earnings vs. Estimates